-
Sub-chronic Effect Of Co-administration Of Methformine And Amilodipine On Some Haematological Indices In Experimental Animal
[A CASE STUDY OF WISTAR RATS]
REFRENCES -- [Total Page(s) 4]
Page 2 of 4
-
-
-
Feldman, B.F., Zinkl, J.G. and Jain, N.C. (2010). Schalm’s Veterinary Hematology (6th Ed.). Baltimore: Lippincott, Williams & Wilkins. Pp: 852-861.
Fredrickson, T.N. and Harris, A.W. (2000). Atlas of Mouse Hematopathology. Amsterdam: Harwood Academic. Pp: 289.
Fliser, D. (2010). Perspectives in renal disease progression: the endothelium as a treatment target in chronic kidney disease. Journal of Nephrology. 23(4): 369-376.
Gherasim, C., Lofgren, M. and Banerjee, R. (2013). Navigating the B-12 Road: Assimilation, Delivery, and Disorders of Cobalamin. Journal of Biological Chemistry. 288(19): 13186- 13193.
Glueck, C.J., Fontaine, R.N., Wang, P., Subbiah, M.T. and Weber, K. (2001). Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in non diabetic, morbidly obese subjects with body mass index greater than 30. Journal of Metabolism. 50: 856-861.
Gnimpieba, E. Z., Eveillard, D., Gueant, J.L. and Chango, A. (2011). Using logic programming for modeling the one-carbon metabolism network to study the impact of folate deficiency on methylation processes. Molecular Biosystems, 7(8), 2508-2521.
Gong, L., Goswami, S., Giacomini, K.M., Altman, R.B. and Klein, T.E. (2012). Metformin pathways: pharmacokinetics and pharmacodynamics. Pharmacogenetics Genomics. 22: 820-827.
Graham, G.G., Punt, J., Arora, M., Day, R.O., Doogue, M.P., Duong, J. K. and Williams, K.M. (2011). Clinical Pharmacokinetics of metformin. Clinical Pharmacokinetics. 50(2): 81-98.
Green, T.J., Venn, B. J., Skeaff, C. M. and Williams, S.M. (2005). Serum vitamin B-12 concentrations and atrophic gastritis in older New Zealanders. European Journal of Clinical Nutritioni. 59(2): 205-210.
Greibe, E., Miller, J. W., Foutouhi, S. H., Green, R. and Nexo, E. (2013). metformin increases liver accumulation of vitamin B12-An experimental study in rats. Biochimie. 95(5): 1062-1065.
Gueant, J. L. and Alpers, D.H. (2013). Vitamin B12, a fascinating micronutrient, which influences human health in the very early and later stages of life. Biochimistry. 95(5): 967-969.
Gungor, N., Hannon, T., Libman, I., Bacha, F. and Arslanian, S. (2005). Type 2 diabetes mellitus in youth: the complete picture to date. Pediatric Clinical North America Journal. 52: 1579- 1609.
Guo, C., Pei, Q. and Tan, H. (2015). Effects of genetic factors on the pharmacokinetics and pharmacodynamics of Amlodipine in primary hypertensive patients, Biomedical Reports Journal. 3(2): 195-200.
Harris, K., and Smith, L. (2013). Safety and Efficacy of metformin in Patients With Type 2 Diabetes Mellitus and Chronic Hepatitis C. Annals of Pharmacotherapy. 47(10): 1348-1352.
Hogan, K.A., Weiler, H. and Lord, S.T. (2002). Mouse models in coagulation. Thrombo Haemostasis. 87: 563 – 574.
Leung, S., Mattman, A., Snyder, F., Kassam, R., Meneilly, G. and Nexo, E. (2010). Metformin induces reductions in plasma cobalamin and haptocorrin bound cobalamin levels in elderlyly diabetic patients. Clinical Biochemistry. 43(9): 759-760.
Iughetti, L., China, M., Berri, R. and Predieri, B. (2011). Pharmacological treatment of obesity in children and adolescents: present and future. Journal of Obesity. 9:211-235.
Kaufman, F.R. (2002). Type 2 Diabetes in Children and Young Adults: A “New Epidemic. Clinical Diabetes Journal. 20: 217-218.
Kibirige, D., Wekesa, C., Kaddu-Mukasa, M. and Waiswa, M. (2013). Vitamin B12 deficiency presenting as an acute confusional state: a case report and review of literature. African Health Science Journal. 13(3): 850-852.
Knowler, W.C., Barrett-Connor, E., Fowler, S.E., Hamman, R.F. and Lachin, J.M. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. National England Journal of Medicine. 346: 393-403.
Kwak, C., Park, J. and Cho, J. (2012). Vitamin B 12 content using modified microbioassay in some Korean popular seaweeds, fish, shellfish and its products. Korean Journal of Nutrition, 45(1): 94-102.
Lakshmi, B., Krishna, K.R. and Jayaveera, K.N. (2015). Development and Validation of Rp-Hplc Method for the Determination of Amlodipine. International Journal of Applied Biology and Pharmaceutical Technology. 6(1): 225-231.
Lee, S., Kim J. and Jung, J.A. (2015). Bioequivalence evaluation of two Amlodipine salts, besylate and orotate, each in a fixed-dose combination with olmesartan in healthy subjects. Journal of Drug Design, Development and Therapy. 9: 2811-2817.
Leone, A., Di Gennaro, E., Bruzzese, F., Avallone, A. and Budillon, A. (2014). New perspective for an old antidiabetic drug: metformin as anticancer agent. Cancer Treat Research. 159: 355-376.
REFRENCES -- [Total Page(s) 4]
Page 2 of 4
-
-
ABSRACT - [ Total Page(s): 1 ]ABSTRACTMetformin, which belongs to the biguanide class, is one of the most generally used oral hypoglycemic agents. It has been used for more than 50 years and was approved by the US Food and Drug Administration (FDA) in 1994 (American Diabetes Association, 2009) whereas Amlodipine is a long acting dihydropyridine calcium channel blocker, which is used in the treatment of angina to lower the BP (Blood pressure). the aim is to know the effect of co-administration of this two drugs in Wistar rats ... Continue reading---
APPENDIX A - [ Total Page(s): 1 ]APPENDIXAPPENDIX 1: MATERIAL USED1% Ammonium oxalate10% Formalin salineAbsorbent paperAutomatic pipetteBrilliant cresyl blueCounting chamber Cyanmethaemoglobin standardDrabkin’s ReagentEDTA sample containerHematoxylin and Eosin stainKhan tubes/rackLeisfhmann stainLight microscopeMicrohaematocrit centrifugeNormal salinePasteur pipettePipette tipsRotary microtomeSpectrophotometerTimer Turk’s solution Universal sample bottle ... Continue reading---
APPENDIX B - [ Total Page(s): 1 ]APPENDIX IITable 1: haematological parameters in control, Metformine treated and Amilodipine treated Rats (Values are expressed as mean ± Standard error of means) Group A(1): control (untreated), Group B(2): co-administration of Metformin 0.00264/ml/132g and Amlodipine 0.000849/ml/132g at a single dose for 30 daysPARAMETERS GROUP A GROUP BPacked cell volume (%) 44.16±2.83 38.47±3.53Red blood cell count (x1012/L) 7 ... Continue reading---
LIST OF TABLES - [ Total Page(s): 1 ]LIST OF TABLESTable 1: Haematological parameters in control, Co-administration of Metformin and Amlodipine treated ... Continue reading---
LIST OF FIGURES - [ Total Page(s): 1 ]LIST OF FIGURESFigure 1: Shows mechanism of action of metformin Figure 2: Shows Pie chat representation of Packed cell volume of control, Co-administration of metformin and amlodipine treated Wistar Rats Figure 3: Shows Histogram representation of Hemoglobin and red blood cell count of control, Co-administration of metformin and amlodipine treated Wistar Rats Figure 4: Shows Histogram representation of red cell indicies of control, Co-administration of metformin and amlodipine t ... Continue reading---
TABLE OF CONTENTS - [ Total Page(s): 1 ]TABLE OF CONTENTTitle page Declaration Certification Dedication Acknowledgement Table of content List of table List of figures Abstract CHAPTER ONE1.0 Introduction 1.1 Background of study 1.2 Statement of Problems 1.3 Justifications 1.4 Aims 1.5 Research Objectives 1.6 Research Hypothesis 1.7 Significance of research CHAPTER TWO2.0 Literature review 2.1 Metformin 2.1.1 ... Continue reading---
CHAPTER ONE - [ Total Page(s): 2 ]CHAPTER ONE1.0 INTRODUCTION1.1 Background of the studyMetformin, which belongs to the biguanide class, is one of the most generally used oral hypoglycemic agents. It has been used for more than 50 years and was approved by the US Food and Drug Administration (FDA) in 1994 (American Diabetes Association, 2009). Currently, many clinical practice guidelines for patients with type 2 diabetes, including the American Diabetes Association (ADA), the European Association for the Study of Diabetes ... Continue reading---
CHAPTER TWO - [ Total Page(s): 12 ]The current use of serum Vitamin B12 level relies on several different range points for Vitamin B12 status. Serum Vitamin B12 level under 148 pmol/L are said to be deficient, low/borderline levels are interpreted from levels between 148-220 pmol/L (Mazokopakis and Starakis, 2012). Normal ranges of Vitamin B12 serum range from 220- 800 pmol/L, levels that exceed this are rarely suspicious in cause, although excessive B12 serum may be a marker of myloproliferative disorders (Pernicova and Korbonit ... Continue reading---
CHAPTER THREE - [ Total Page(s): 4 ]From the above table,Km of rats= 6 Km of human= 37For Amlodipine, Human dose= 10mg/70kg 1kg=10/70 =0.14mg/kgAED of Amilodipine= 0.14×(6/37) =0.02mg/kgAverage weight of experimental Animal is 132g(0.132kg)If 0.02mg of Amlodipine is administered per kg.bw,(0.02×0.132)mg of Amlodipine was administered to ... Continue reading---
CHAPTER FOUR - [ Total Page(s): 6 ]CHAPTER FOUR4.0 Results4.1 Hematological parameter in control and test groups As summarized in table 1, the mean RBC counts were 7.62 ± 2.83 x1012/L for the control and 6.53 ± 0.57 x1012/L for co-administration of metformin and amlodipine fed groups respectively. Although, decrease in RBC counts was observed in the treated (co-administration of metformin and amlodipine) dose group, these were statistically significant compared to control groups (student t test P0.05) higher in the tr ... Continue reading---
CHAPTER FIVE - [ Total Page(s): 2 ]CHAPTER FIVE5.0 DiscussionMetformin (1,1-dimethylbiguanide) is the most widely used drug to treat type 2 diabetes, and is one of only two oral anti-diabetic drugs on the World Health Organization (WHO) list of essential medicines (American Diabetes Association, 2009). Amlodipine is a long acting dihydropyridine calcium channel blocker, which is used in the treatment of angina to lower the BP. Co-administration of Metformin and Amlodipine have been discovered to lead to vitamin B12 deficiency. Al ... Continue reading---
